Nisa Investment Advisors LLC Grows Position in Privia Health Group, Inc. $PRVA

Nisa Investment Advisors LLC raised its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 155.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,592 shares of the company’s stock after buying an additional 7,666 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Privia Health Group were worth $290,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in PRVA. MQS Management LLC grew its holdings in shares of Privia Health Group by 8.5% in the second quarter. MQS Management LLC now owns 10,167 shares of the company’s stock valued at $234,000 after purchasing an additional 795 shares in the last quarter. State of New Jersey Common Pension Fund D grew its stake in shares of Privia Health Group by 3.3% in the 2nd quarter. State of New Jersey Common Pension Fund D now owns 81,534 shares of the company’s stock worth $1,875,000 after buying an additional 2,607 shares in the last quarter. AlphaQuest LLC grew its stake in shares of Privia Health Group by 22.5% in the 2nd quarter. AlphaQuest LLC now owns 8,189 shares of the company’s stock worth $188,000 after buying an additional 1,503 shares in the last quarter. Moran Wealth Management LLC purchased a new position in shares of Privia Health Group in the 2nd quarter worth $700,000. Finally, Yousif Capital Management LLC grew its stake in shares of Privia Health Group by 2.5% in the 2nd quarter. Yousif Capital Management LLC now owns 39,687 shares of the company’s stock worth $913,000 after buying an additional 955 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Stephens reiterated an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research report on Wednesday, September 24th. Citigroup reiterated an “outperform” rating on shares of Privia Health Group in a report on Friday, August 29th. Piper Sandler dropped their target price on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a report on Monday, August 11th. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Privia Health Group in a research note on Wednesday, October 8th. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $28.91.

Privia Health Group Stock Up 1.9%

PRVA opened at $24.76 on Tuesday. The business has a fifty day moving average of $23.96 and a 200 day moving average of $22.73. Privia Health Group, Inc. has a 52-week low of $18.50 and a 52-week high of $26.49. The stock has a market cap of $3.04 billion, a P/E ratio of 225.11, a PEG ratio of 3.31 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. Equities analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.